On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...